Facebook Facebook Share

We have received a number of awards in recognition of our work to improve early diagnosis, fund life saving research and provide much needed support to women with ovarian cancer. 

BMA awardsBritish Medical Association Patient Information Awards

Our Genetic testing and hereditary ovarian cancer guide won two awards in the 2017 awards ceremony. The guide won a special award for patient information on screening and came runner up in the award for inforamtion on ethical issues.

Winner of patient information on screening at the 2017 BMA awards      Runner up of award for information on ethical issues.

Target Ovarian Cancer's joint guide 'A younger woman's guide to ovarian cancer' won a British Medical Association (BMA) Patient Information Award 2016 and came runner up in the special category for information about long term conditions. 

 Target Ovarian Cancer’s symptoms leaflet won a British Medical Association (BMA) Patient Information Award 2015. Our symptoms leaflet is one of our core pieces of information to help improve early diagnosis for women concerned about symptoms.

In 2014, our online Clinical Trials Information Centre won a 'Special award for user involvement', and Looking after me, our guide which aims to improve the quality of life of women with ovarian cancer that is terminal or life limiting, was also highly commended.

Communique awards finalistCommunique awards 2017

Target Ovarian Cancer were selected as a finalist for the Excellence in Media Relations – Healthcare award at the Communique 2017 awards for healthcare communications for our work on Pathfinder 2016.

GSK IMPACT Awards

Target Ovarian Cancer accepts 20th Anniversary Impact AwardTarget Ovarian Cancer is extremely proud to have been announced the winner of a special GSK IMPACT Award in 2017, the 20th Anniversary Award. All overall winners of the GSK IMPACT Award since 2010 were shortlisted. The awards recognise charities that have made an outstanding contribution to improving health and wellbeing in the UK. They are funded by GlaxoSmithKline and managed in partnership with The King’s Fund.

Target Ovarian Cancer was overall winner of the 2012 GSK IMPACT Awards, for the work we do improving survival and quality of life for women with ovarian cancer across the UK.

2016 International Life Sciences Awards

Target Ovarian Cancer were awarded the Best Ovarian Cancer Support Agency - UK award at the 2016 International Life Sciences Awards by Global Health and Pharma magazine.

Women's Health Blog Award 2016

Target Ovarian Cancer's website was recognised with a Women's Health Blog Award 2016 - an awards for blogs, websites and charities that help to support and empower women, selected by a panel of experts and coordinated by HealthExpress. 

Third Sector Awards FinalistThird Sector Excellence Awards

The Third Sector Excellence Awards recognise those who give back to the community and celebrate organisations and social leaders from across the sector. In 2015, our Chair, Joanna Barker, was nominated for 'Charity Chair of the year', and ambassador Annie Mulholland was nominated for 'Volunteer of the year'.

Charity Times Awards

The Charity Times Awards celebrate best practice in the UK charity and not-for-profit sector. In 2015, we were shortlisted for 'Best use of web' for our website. We are particularly proud of the role that women with ovarian cancer had in developing our new site (launched in 2014) - both in shaping its structure and in featuring throughout the content. Since launch, the number of people visiting our site to get support and information has significantly increased.

 

Association of Medical Research Charities (AMRC) Science Communication Awards

amrc-award

Target Ovarian Cancer’s Clinical Trials Information Centre won 'Best entry from a small charity (for charities with a research spend under £1m)' at the AMRC Science Communication Awards 2014. It was also runner up for ‘Online and social media’.

The Clinical Trials Information Centre is an online tool that allows women with ovarian cancer to quickly and easily search for clinical trials that could benefit them.

It was praised for its layout and intuitiveness, and for providing much needed information, clearly tailored to its target audience.

Excellence in Oncology Awards

Target Ovarian Cancer's BMJ Learning module for GPs was highly commended in the ‘Best professional education’ category at the Excellence in Oncology Awards in 2010.

The free online tool enables GP to update their knowledge on ovarian cancer symptoms through an interactive hour-long course. The judges said it showed great potential to influence the diagnosis of ovarian cancer.

Read our awards news

News
BMA awards certificates
Monday 18 September 2017
Target Ovarian Cancer is thrilled to announce that our guide Genetic testing and hereditary ovarian cancer has won a special award for patient information on screening at the 2017 British Medical Association (BMA) Patient Information Awards. Our information guide also came runner up in the award...
News
Target Ovarian Cancer accepts 20th Anniversary Impact Award
Friday 19 May 2017
Target Ovarian Cancer is extremely proud to have been announced the winner of a special GSK IMPACT Award at a packed ceremony last night at London’s Science Museum. As part of the 20th GSK IMPACT Awards, run in partnership with The King’s Fund, a special 20th Anniversary Award had been created to...
News
Amanda and Sarah at the BMA Awards
Tuesday 13 September 2016
Target Ovarian Cancer is extremely proud to announce that A younger woman’s guide to ovarian cancer, produced together with Ovacome, Ovarian Cancer Action and The Eve Appeal has been highly commended in this year’s British Medical Association (BMA) Patient Information Awards. We also came second in...
News
Tuesday 8 September 2015
Target Ovarian Cancer is extremely proud to announce that our symptoms leaflet has been highly commended in this year’s British Medical Association (BMA) Patient Information Awards. Our symptoms leaflet is one of our core pieces of information to help improve early diagnosis for women concerned...

Pages